Chronic lymphocytic leukemia with two cellular populations: a biphenotypic or biclonal disease

J González-Campos1, E Ríos-Herranz, J M De Blas-Orlando

  • 1Department of Hematology and Hemotherapy, Hospital Universitario Virgen del Rocio, Sevilla, Spain.

Insights

This case study reports chronic lymphocytic leukemia (CLL) in a 50-year-old man, revealing two distinct leukemic cell populations. Gene rearrangement studies confirmed the presence of at least two monoclonal cell populations.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Chronic lymphocytic leukemia (CLL) is a heterogeneous lymphoproliferative disorder.
  • Diagnosis typically relies on immunophenotyping and molecular analyses.
  • Rare cases may present with complex cellular or genetic profiles.

Observation:

  • A 50-year-old male presented with persistent absolute lymphocytosis and numerous small lymphocytes on peripheral blood smear.
  • Bone marrow examination revealed 85% lymphocytes with a mixed nodular-interstitial infiltration pattern.
  • Immunophenotypic analysis identified two distinct leukemic B-cell populations with differing CD18, CD22, and FMC7 expression, but shared CD5, CD19, CD20, CD23, and lambda light chain restriction.

Findings:

  • Gene rearrangement studies, specifically immunoglobulin heavy chain (IgH) gene analysis, detected multiple rearranged bands.
  • The detection of three rearranged bands in the Jh blot indicated the presence of at least two independent B-cell clones.
  • These molecular findings correlated with the distinct immunophenotypic profiles of the two observed leukemic cell populations.

Implications:

  • This case highlights the potential for clonal heterogeneity in chronic lymphocytic leukemia.
  • The presence of multiple monoclonal populations may have implications for understanding CLL pathogenesis and treatment response.
  • Further research is warranted to explore the clinical significance and biological basis of dual-clone CLL.